Global Hemp Group Inc.

OTC: GBHPF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ North Vancouver, BCReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 33

v0.1 · 5/100 weight · pillars only

↑ listing tenure, disclosure history · ↓ 3-yr revenue growth, return on assets

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$1.9M

Employees

Market cap

$2.4k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2023

Net income-$1.9M-2.6M CAD2023

Operating income-$412.3k-556.0k CAD2023

Total assets$31.6k42.8k CAD2023

Liabilities$4.3M5.8M CAD2023

Equity-$4.3M-5.8M CAD2023

Revenue trend

FY2017 – FY2023 · USD

FY17

FY18

$2.0k

FY19

$21.5k

FY20

FY21

FY22

FY23

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Global Hemp Group Inc. booked $0 in FY2023 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Southwestern Medical Solutions, Inc.——OncoVista Innovative Therapies, Inc.——Khiron Life Sciences Corp.——Longport, Inc.——

Key facts

CEOCurtis Ralph William Huber

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersNorth Vancouver, BC

ExchangeOTC: GBHPF

Employees18

IPO date2014-04-22

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.